| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | Jun 20, 2025 | Akero Therapeutics, Inc. | Chief Technology Officer | Sell | 46.3 | -848 | -3.49% | ✗ | $46.5K |
| Nov 9, 2016 | Nov 14, 2016 | Outlook Therapeutics, Inc. | SVP, Development & Mfrg | Sell | 42.5 | -37,369 | -32.23% | ✗ | $140.1K |